全文获取类型
收费全文 | 5190篇 |
免费 | 210篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 134篇 |
儿科学 | 140篇 |
妇产科学 | 229篇 |
基础医学 | 614篇 |
口腔科学 | 56篇 |
临床医学 | 414篇 |
内科学 | 1414篇 |
皮肤病学 | 113篇 |
神经病学 | 299篇 |
特种医学 | 94篇 |
外科学 | 704篇 |
综合类 | 43篇 |
一般理论 | 1篇 |
预防医学 | 289篇 |
眼科学 | 74篇 |
药学 | 392篇 |
中国医学 | 4篇 |
肿瘤学 | 404篇 |
出版年
2023年 | 23篇 |
2022年 | 118篇 |
2021年 | 212篇 |
2020年 | 63篇 |
2019年 | 99篇 |
2018年 | 124篇 |
2017年 | 91篇 |
2016年 | 110篇 |
2015年 | 129篇 |
2014年 | 167篇 |
2013年 | 227篇 |
2012年 | 385篇 |
2011年 | 442篇 |
2010年 | 203篇 |
2009年 | 120篇 |
2008年 | 333篇 |
2007年 | 378篇 |
2006年 | 349篇 |
2005年 | 339篇 |
2004年 | 348篇 |
2003年 | 346篇 |
2002年 | 256篇 |
2001年 | 50篇 |
2000年 | 29篇 |
1999年 | 36篇 |
1998年 | 30篇 |
1997年 | 32篇 |
1996年 | 15篇 |
1995年 | 20篇 |
1994年 | 9篇 |
1993年 | 22篇 |
1992年 | 32篇 |
1991年 | 12篇 |
1990年 | 20篇 |
1989年 | 22篇 |
1988年 | 11篇 |
1987年 | 21篇 |
1986年 | 20篇 |
1985年 | 20篇 |
1984年 | 13篇 |
1983年 | 15篇 |
1982年 | 7篇 |
1981年 | 11篇 |
1979年 | 9篇 |
1977年 | 11篇 |
1976年 | 12篇 |
1974年 | 8篇 |
1972年 | 7篇 |
1970年 | 9篇 |
1967年 | 6篇 |
排序方式: 共有5418条查询结果,搜索用时 15 毫秒
101.
Jacek A. ?migielski ?ukasz Piskorz Marcin Wawrzycki Przemys?aw Dobielski Ma?gorzata Pikala S?awomir Jab?oński Marian Brocki 《Archives of Medical Science》2013,9(4):677-683
Introduction
We would save many lives and spare a lot of suffering if we could only detect and accurately determine the character and TMN staging of pancreatic tumors (PTs). With improved diagnosis, we could offer specific treatment that would result in better treatment outcome. The aim of study was to determine the significance of neoplastic markers CA 19-9 and CEA for prognosis in inflammatory and carcinomatous PTs.Material and methods
We based our research upon a group of 170 patients. The patients were treated in our Oncologic Surgery Department from January 2007 to December 2010 for PTs. The patients were divided into four groups depending on the character of the tumor and underwent the following treatments: group 1 – 34 patients with carcinoma of the ampulla of Vater, group 2 – 64 patients with PTs at different stages (1, 2, 3) according to TMN classification, group 3 – 62 patients with PTs at stage 4 on the TMN scale (unresectable tumors), group 4 – 28 patients with inflammatory PTs.Results
The results of Ca 19-9 in group 2 were 736.00 (25–75% 220.40–4285.00) ng/ml before surgery, 53.00 (25–75% 12.60–84.00) ng/ml in the 7 days after surgery, 29.4 (25–75% 7.90–113.00) ng/ml at day 30, and 119.00 (25–75% 96.30–621.00) ng/ml 3 months after the operation. These results were significantly higher than the control group but were significantly lower than the results for group 3 (unresectable tumors). The highest average concentration and median for CA 19-9 and CEA were noted in patients with unresectable PTs (the 3rd group). The average concentration for CEA was lowest in group 4, but much higher than the lab limits.Conclusions
The sensitivity of the CA 19-9 marker may be as high as 88%. Values of CA 19-9 above 852 U/ml may indicate TNM stage 4, consistent with an unresectable PT. In the cases where CA 19-9 is within normal limits but C-reactive protein is above normal limits (often thirty times the upper limit), in comparison to the control group and to patients with pancreatic neoplasms, strong consideration should be given towards the inflammatory characteristics of the pancreatic changes and conservative treatment should be applied. 相似文献102.
Beata Franczyk-Skóra Anna Gluba Maciej Banach Jacek Rysz 《Archives of Medical Science》2013,9(6):1019-1027
Renal dysfunction is frequent in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS). Chronic kidney disease (CKD) is associated with very poor prognosis and is an independent predictor of early and late mortality and major bleeding in patients with NSTE-ACS. Patients with NSTE-ACS and CKD are still rarely treated according to guidelines. Medical registers reveal that patients with CKD are usually treated with too high doses of antithrombotics, especially anticoagulants and inhibitors of platelet glycoprotein (GP) IIb/IIIa receptors, and therefore they are more prone to bleeding. Drugs which are excreted mainly or exclusively by the kidney should be administered in a reduced dose or discontinued in patients with CKD. These drugs include enoxaparin, fondaparinux, bivalirudin, and small molecule inhibitors of GP IIb/IIIa inhibitors. In long-term treatment of patients after myocardial infarction, anti-platelet therapy, lipid-lowering therapy and β-blockers are used. Chronic kidney disease patients before qualification for coronary interventions should be carefully selected in order to avoid their use in the group of patients who could not benefit from such procedures. This paper presents schemes of non-ST and ST-segment elevation myocardial infarction treatment in CKD patients in accordance with the current recommendations of the European Society of Cardiology (ESC). 相似文献
103.
Tomasz Lyson Andrzej Sieskiewicz Andrzej Sobolewski Robert Rutkowski Jan Kochanowicz Grzegorz Turek Anna Baclawska Jacek Krajewski Marek Rogowski Zenon Mariak 《Acta neurochirurgica》2013,155(5):903-908
Background
Data regarding the safety of endoscopic skull base exploration are very scarce. With this method, fragile vital structures (cranial nerves, the optic complex, brainstem, hypothalamus or cerebral ventricles) are exposed to direct illumination within a closed space. Also, high-speed drills, cauterization and ultrasonic aspiration deliver a significant load of thermal energy. The aim of this study was to record the temperature close to the structures of the skull base and in the intradural space during the procedures performed using extended endoscopic transnasal approaches.Methods
The temperature of the skull base was continuously recorded during six transnasal endoscopic procedures. Implantable copper-constantan thermocouples were inserted: one into the esophagus and another through the nostril to reach the operative field at the skull base.Results
At the beginning of the procedure, the temperature of the operative field was on average 36.8 °C?±?0.80 °C, i.e. only 1 °C higher than the esophageal temperature. Then it grew continuously during the whole procedure, to eventually reach a level of 42–43 °C at the final stage, whereas the esophageal temperature remained stable. Occasionally, the temperature increased up to 45 °C during cauterization and ultrasonic aspiration, and even up to 62 °C during high-speed drilling.Conclusion
Endoscopic skull base surgery is associated with an incessant increase of the temperature of the intraoperative field. The temperature can peak suddenly to levels which can potentially harm neural structures and influence the rate of postoperative complications. 相似文献104.
Politicians often deplore economic agents’ behaviour when they do not accept new technologies. For a new technology to be adopted, the new technology value function needs to dominate the old technology value function. If this is the case, a technology switch will occur. We characterise the value functions, without computing them, using the fact that their hypographs are viability kernels of some auxiliary control problems and study whether the graphs intersect. If they do not, the corresponding value functions do not dominate each other, and the switch cannot occur at a positive time. Using this characterisation, we analyse a technology adoption problem and show how to recognise the models, for which the switch will occur at time zero or never, without solving an optimal control problem. We conclude that the current control regime may not change if the economic agents’ preferences are modelled as an integral of discounted differences between a reward from the flow variable (control) and a penalty from the stock variable (state).Copyright © 2011 John Wiley & Sons, Ltd. 相似文献
105.
106.
Sylwia Olechnowicz-Tietz Anna Gluba Anna Paradowska Maciej Banach Jacek Rysz 《International urology and nephrology》2013,45(6):1605-1612
Background
Chronic kidney disease (CKD) is becoming a serious health problem; the number of people with impaired renal function is rapidly rising, especially in industrialized countries. A major complication of CKD is cardiovascular disease. Accelerated atherosclerosis has been observed in early stages of renal dysfunction. The purpose of this study was to examine the relationship between the degree of renal insufficiency and both the prevalence and intensity of coronary artery disease (assessed on the basis of number of vessels with stenosis).Methods
446 individuals with both serum creatinine >120 μmol/l (men) or >96 μmol/l (women) and acute coronary syndrome were included in the study. All patients included in this analysis underwent urgent coronarography. Data concerning glomerular filtration rate (GFR), number of vessels with stenosis, hypertension, lipid disorders, creatinine concentration, C-reactive protein, glucose and lipid profile were analyzed.Results
This study confirmed that moderate to severe renal impairment is associated with accelerated atherosclerosis. Moreover, patients with GFR values below 60 ml/min/1.73 m2 are predisposed to accelerated, multivessel cardiovascular disease.Conclusions
GFR seems to be an independent risk factor for multivessel cardiovascular disease. Due to the fact that patients with renal dysfunction are at high risk of cardiovascular events, they should obtain optimal treatment resulting not only in kidney protection but also in the elimination of cardiovascular risk factors. 相似文献107.
Exhaled breath condensate (EBC) contains extracellular DNA that may originate from pathological lesions of the respiratory tract and can be a genetic marker of pulmonary malignancy. We tested whether complete surgical excision of lung cancer will decrease exhalation of mutated KRAS oncogene. Fifty seven patients with clinical diagnosis of lung cancer and detectable KRAS mutations in pre-surgery EBC-DNA were qualified for surgical treatment. Point mutations at codon 12 of KRAS oncogene were detected using mutant-enriched PCR technique in DNA from pre-surgery blood, EBC collected before, 7 and 30 days after surgery and from specimens of resected tumor and normal pulmonary parenchyma. The ratio of mutated to wild type KRAS DNA (R mut/wild KRAS) was calculated for each specimen after electrophoresis and densitometry of the final amplification and digestion product. In 46 patients non-small cell lung cancer (NSCLC) and in 11 benign lesion (BL) were confirmed. All blood and tumor specimens were positive for KRAS mutations, while 41 specimens of normal pulmonary parenchyma were negative. In NSCLC patients pre-surgery EBC R mut/wild KRAS of 0.20?±?0.03 decreased by 1.3- and 3.7-times (p?0.001) at 7th and 30th day and 10 EBC specimens at day 30th became negative. The highest R mut/wild KRAS was found in NSCLC specimens - 1.36?±?0.29 while the lowest in pulmonary parenchyma - 0.02?±?0.03 (p?0.001). R mut/wild KRAS in EBC did not correlate with the blood and cancer ratios. Determination of mutated KRAS oncogene in EBC can be potentially helpful in the follow-up of surgical treatment of pulmonary malignancy. 相似文献
108.
109.
Hepcidin is the key regulator of iron metabolism. Iron supplementation is often introduced in dialyzed patients to replete or to maintain iron stores, particularly in patients treated with erythropoietic-stimulating agents. The present study was aimed to assess possible relation between hepcidin and erythropoietin therapy, with particular attention being paid to erythropoietin-hyporesponsiveness in hemodialyzed patients. Prohepcidin and hepcidin were studied using commercially available kits from DRG Instruments GmbH, Germany (ELISA method) and Bachem, UK (RIA method). TNFα and IL-6 were studied using kits from and R&D (Abington, UK), and hsCRP was studied using kits from American Diagnostica, USA. Hyporesponsive patients to erythropoietin therapy had significantly lower serum albumin, cholesterol, LDL, hemoglobin, hematocrit, and residual renal function, and significantly higher serum ferritin, hsCRP, IL-6, TNFα, and erythropoietin dose. The difference in serum prohepcidin and hepcidin did not reach statistical significance; however, there was a tendency toward higher values of both prohepcidin and hepcidin in hyporesponsive patients. In conclusion, though hyporesponsiveness to erythropoietin therapy occur in dialyzed patients, it is mainly associated with subclinical inflammation than with hepcidin excess. Further studies are needed to develop a reliable and reproducible assay to elucidate the potential contribution of hepcidin to hyporesponsiveness during erythropoietin therapy. 相似文献
110.
Jacek B. Kowalczewski Lidia Rutkowska-Sak Dariusz Marczak Iwona Słowińska Radosław Słowiński Marcin Sibiński 《International orthopaedics》2013,37(4):595-598